Finally, the IDH1 mutations prevalent in lower grade gliomas and recurrent glioblastomas appear to induce their oncogenic effects, at least partly, by heightening the oxidative stress and inflammatory responses. The gene discussed is IDH1; the disease is glioblastoma.